Post job

Haemonetics main competitors are Amgen, Seagen, and Corning Incorporated.

Competitor Summary. See how Haemonetics compares to its main competitors:

  • Johnson & Johnson has the most employees (134,500).
  • Employees at Amgen earn more than most of the competitors, with an average yearly salary of $93,349.
Work at Haemonetics?
Share your experience

Haemonetics vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1971
4.6
Braintree Town, MA6$1.3B3,300
1985
4.4
Marlborough, MA10$4.0B6,478
1931
4.2
Deerfield, IL6$10.6B48,000
1851
4.5
Corning, NY30$13.1B51,500
1886
4.7
New Brunswick, NJ26$88.8B134,500
1969
4.6
Washington, DC39$23.9B80,000
1996
4.8
Silver Spring, MD6$2.9B950
1997
4.7
Bothell, WA3$2.0B900
1980
4.8
Thousand Oaks, CA9$33.4B22,000
-
3.5
Dayton, OH1$1.6M30
1906
4.3
Norwalk, CT2$6.2B24,700
1946
4.8
Port Washington, NY1$2.8B10,900
2004
4.8
Lake Forest, IL1$4.5B19,000
1952
4.2
Saint Paul, MN1$57.7M200
1867
4.8
Hazelwood, MO5$1.0B3,400
1995
4.3
Middlesex, NJ1$15.0M200
1979
4.7
San Diego, CA3$1.7B1,500
1942
4.1
Chesterfield, MO1$91.0M7,500
1961
4.4
Harleysville, PA1$750.0M350
Caraco Pharmaceutical Laboratories
-
4.0
Detroit, MI1--
2007
4.4
Somerset, NJ14$4.4B14,000

Rate Haemonetics' competitiveness in the market.

Zippia waving zebra

Haemonetics salaries vs competitors

Among Haemonetics competitors, employees at Amgen earn the most with an average yearly salary of $93,349.

Compare Haemonetics salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Haemonetics
$64,516$31.02-
Hologic
$72,888$35.04-
Baxter International
$54,368$26.14-
Corning Incorporated
$77,020$37.03-
Johnson & Johnson
$76,686$36.87-
Danaher
$65,463$31.47-

Compare Haemonetics job title salaries vs competitors

CompanyHighest salaryHourly salary
Haemonetics
$115,004$55.29
Quidel
$163,052$78.39
United Therapeutics
$138,728$66.70
Corning Incorporated
$136,259$65.51
Seagen
$132,193$63.55
Amgen
$131,979$63.45
Hologic
$126,454$60.80
Hospira
$125,393$60.29
Johnson & Johnson
$119,355$57.38
Catalent Pharma Solutions
$119,247$57.33
Baxter International
$118,447$56.95
Tapemark
$117,286$56.39
Colorcon
$116,950$56.23
Xerox
$114,064$54.84
CorePharma
$113,997$54.81
KV Pharmaceutical
$113,065$54.36
Caraco Pharmaceutical Laboratories
$112,083$53.89
Ardent Technologies
$111,626$53.67
Mallinckrodt
$107,458$51.66
Pall
$95,298$45.82

Do you work at Haemonetics?

Does Haemonetics effectively differentiate itself from competitors?

Haemonetics jobs

Haemonetics demographics vs competitors

Compare gender at Haemonetics vs competitors

Job titleMaleFemale
Amgen57%43%
Catalent Pharma Solutions57%43%
Baxter International59%41%
Haemonetics63%37%
Corning Incorporated66%34%
Danaher70%30%

Compare race at Haemonetics vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
63%15%8%11%3%
9.9
49%24%7%15%5%
9.7
57%19%9%11%4%
9.9
60%16%10%9%4%
9.7
60%12%13%12%4%
9.9
60%13%12%11%4%
9.9

Haemonetics revenue vs competitors

Haemonetics revenue is $1.3B. Among it's competitors, the company with the highest revenue is Johnson & Johnson, $88.8B . The company with the lowest revenue is Catalent Pharma Solutions, $4.4B.

Haemonetics and similar companies CEOs

CEOBio
Robert A. Bradway
Amgen

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

​Jose E. Almeida
Baxter International

José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.

Wendell P. Weeks
Corning Incorporated

Wendell P. Weeks (born 1959/60) is an American businessman, the chairman, CEO, and president of Corning Inc.

Rainer M. Blair
Danaher

Stephen P. MacMillan
Hologic

Joaquin Duato
Johnson & Johnson

Douglas C. Bryant
Quidel

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Roger D. Dansey
Seagen

Martine A. Rothblatt Ph.D., Mba
United Therapeutics

Founder of Sirius XM radio and United Therapeutics. Progressive technologist and green energy advocate. Helicopter, fixed wing pilot.

John Visentin
Xerox

John Visentin is vice chairman and chief executive officer of Xerox Corporation. He was appointed to this position effective May 14, 2018. John has managed multibillion dollar business units in the IT services industry - at both Hewlett-Packard and IBM - and over the course of his career has a proven track record transforming complex operations to consistently drive profitable growth. Before joining Xerox, John was a senior advisor to the chairman of Exela Technologies and an operating partner for Advent International, where he provided advice, analysis and assistance with respect to operational and strategic business matters in the due diligence and evaluation of investment opportunities. John was also a consultant to Icahn Capital in connection with a proxy contest at Xerox Corporation from March 2018 to May 2018. From October 2013 through July 2017, John served as the executive chairman and chief executive officer of Novitex Enterprise Solutions. Additionally, John was an advisor with Apollo Global Management and contributed to their February 2015 acquisition of Presidio, the leading provider of professional and managed services for advanced IT solutions. He was chairman of the board of Presidio from February 2015 to November 2017. John graduated from Concordia University in Montreal, Canada, with a bachelor’s degree in Commerce.

Haemonetics competitors FAQs

Search for jobs